These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 14588079)

  • 1. Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis.
    González-Pérez A; García Rodríguez LA; López-Ridaura R
    BMC Cancer; 2003 Oct; 3():28. PubMed ID: 14588079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
    Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and cancer risk: an updated quantitative review to 2005.
    Bosetti C; Gallus S; La Vecchia C
    Cancer Causes Control; 2006 Sep; 17(7):871-88. PubMed ID: 16841255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin and other nonsteroid anti-inflammatory drugs as cancer-preventive agents.
    Greenberg ER; Baron JA
    IARC Sci Publ; 1996; (139):91-8. PubMed ID: 8923021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer.
    Johnson TW; Anderson KE; Lazovich D; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1586-91. PubMed ID: 12496048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
    Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
    J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
    Peleg II; Maibach HT; Brown SH; Wilcox CM
    Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and other nonsteroidal anti-inflammatory drugs and breast cancer incidence in a large U.S. cohort.
    Jacobs EJ; Thun MJ; Connell CJ; Rodriguez C; Henley SJ; Feigelson HS; Patel AV; Flanders WD; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):261-4. PubMed ID: 15668504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and NSAID use: a meta-analysis.
    Khuder SA; Mutgi AB
    Br J Cancer; 2001 May; 84(9):1188-92. PubMed ID: 11336469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs and subsite-specific colorectal cancer incidence in the Iowa women's health study.
    Mahipal A; Anderson KE; Limburg PJ; Folsom AR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1785-90. PubMed ID: 17035383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and nonsteroidal anti-inflammatory drugs: prospective results from the Women's Health Initiative.
    Harris RE; Chlebowski RT; Jackson RD; Frid DJ; Ascenseo JL; Anderson G; Loar A; Rodabough RJ; White E; McTiernan A;
    Cancer Res; 2003 Sep; 63(18):6096-101. PubMed ID: 14522941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing.
    Collet JP; Sharpe C; Belzile E; Boivin JF; Hanley J; Abenhaim L
    Br J Cancer; 1999 Sep; 81(1):62-8. PubMed ID: 10487613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.
    Platz EA; Rohrmann S; Pearson JD; Corrada MM; Watson DJ; De Marzo AM; Landis PK; Metter EJ; Carter HB
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):390-6. PubMed ID: 15734963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
    Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
    Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
    Lindblad M; Lagergren J; García Rodríguez LA
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):444-50. PubMed ID: 15734971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-steroidal anti-inflammatory drugs and chemoprevention of cancer.
    Vainio H; Morgan G
    Ann Chir Gynaecol; 2000; 89(3):173-6. PubMed ID: 11079784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs and selective apoptotic anti-neoplastic drugs in the prevention of colorectal cancer: the role of super aspirins.
    Strul H; Arber N
    Isr Med Assoc J; 2000 Sep; 2(9):695-702. PubMed ID: 11062772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nonsteroidal anti-inflammatory drugs and the risk of polyposis, colon carcinoma and rectal carcinoma].
    Gao X; Sun S; Sun F; Li M; Sun H; Zhang W; Song S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Sep; 36(5):332-5. PubMed ID: 12411196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and risk of colorectal cancer: a meta-analysis.
    Larsson SC; Orsini N; Wolk A
    J Natl Cancer Inst; 2005 Nov; 97(22):1679-87. PubMed ID: 16288121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
    Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.